Advertisements
Feeds:
Posts
Comments

Search Results for 'STATIN'


Reversing Heart Disease: Combination of PCSK9 Inhibitors and Statins – Opinion by Steven Nissen, MD, Chairman of Cardiovascular Medicine at Cleveland Clinic Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 2/25/2019 https://www.medpagetoday.com/cardiology/prevention/78202?xid=nl_mpt_SRCardiology_2019-02-25&eun=g99985d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=CardioUpdate_022519&utm_term=NL_Spec_Cardiology_Update_Active While nearly 10% of middle-age adults in China have high risk for cardiovascular disease, only 0.6% of these high-risk individuals use statins and 2.4% […]

Read Full Post »


Perioperative Statins at Noncardiac Surgery: Survival Up, Complications Down Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 11/26/2018   Clinical Trial: Statins Evaluation in Coronary Procedures and Revascularization (SECURE-PCI) A Cardio-Endo Connection selection by Dharam J. Kumbhani, MD, SM (Trial Summary); Deepak L. Bhatt, MD, MPH (Summary Reviewer) Contribution to Literature: The Statins Evaluation in Coronary […]

Read Full Post »


Efficacy and Tolerability of PCSK9 Inhibitors by Patients with Muscle-related Statin Intolerance – New Cleveland Clinic study published in JAMA 4/2016 Curators: Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN   Medical Interpretation of Study Results and the Pharmacological Treatment Context of PCSK9 Inhibitors Author: Larry H. Bernstein, MD, FCAP    The Rausse-3 Clinical […]

Read Full Post »


Praluent – FDA approved as Cholesterol-lowering Medicine for Patient non responsive to Statin due to Genetic origin of Hypercholesterolemia Reporter: Aviva Lev-Ari, PhD, RN Regeneron hasn’t announced its price for Praluent, but CEO Leonard Schleifer, above, said “we’ve come up with a price that provides value to the health-care system.” PHOTO: ASSOCIATED PRESS By RON […]

Read Full Post »


What’s the Story with Statins and Stroke Prevention? – A Q&A with Koto Ishida, MD HCPLive My patients are at high risk for future cardiovascular (CV) events; most have already had a stroke or a transient ischemic attack (TIA). Source: news.google.com See on Scoop.it – Cardiovascular and vascular imaging

Read Full Post »


Guideline Critics Shift Attacks From Beta Blockers To Statins Forbes With the release today of updated European and US guidelines the ongoing controversy regarding beta-blockers appears to be resolved. Source: http://www.forbes.com See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Read Full Post »


Risk of Major Cardiovascular Events by LDL-Cholesterol Level (mg/dL): Among those treated with high-dose statin therapy, more than 40% of patients failed to achieve an LDL-cholesterol target of less than 70 mg/dL. Reporter: Aviva Lev-Ari, PhD, RN       Heartwire Lower LDL Still Best: Very Low Levels of LDL Linked with Reduced CV Events […]

Read Full Post »


Medscape Statins in Very Elderly Adults (Debate) Medscape It contrasted the effects of intensive statin therapy with those of moderate statin therapy on reduction of myocardial ischemia in participants.

Read Full Post »


Boston Heart Diagnostics (BHD) offers Statin Induced Myopathy (SLCO1B1) Genotype test and genetic tests targeting ApoE, Factor V Leiden, prothrombin (Factor II), and CYP2C19 Reporter: Aviva Lev-Ari, PhD, RN Boston Heart Dx Completes New York’s Clinical Lab Permitting Process April 17, 2014 By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Boston Heart Diagnostics today […]

Read Full Post »


CVD Prevention and Evaluation of Cardiovascular Imaging Modalities: Coronary Calcium Score by CT Scan Screening to justify or not the Use of Statin Curator: Aviva Lev-Ari, PhD, RN Opinion Leader:  Khurram Nasir, M.D., MPH One of four Symposium Directors 2014 12th Annual Cardiovascular Disease Prevention International Symposium  Thursday – Sunday, February 6-9, 2014 Fontainebleau Hotel, Miami Beach, Florida As […]

Read Full Post »

Next »